EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine‐Primed Human Astrocytes

Marlen Alisch iD, Franziska Foersterling, Dario Zocholl, Bakhrom Muinjonov, Patrick Schindler, Ankelien Duchnow, Carolin Otto, Klemens Ruprecht, Tanja Schmitz-Hübsch, Sven Jarius, Friedemann Paul, Volker Siffrin iD

Glia · 2025

DOI: 10.1002/glia.24675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, 2025. Verfasst von Marlen Alisch und 11 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Research Center, Max-Delbrück-Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Astrocytes, Aquaporin 4, Neuromyelitis Optica, Cytokines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuromyelitis optica spectrum disorders (NMOSD) are severe autoimmune conditions affecting the central nervous system. In a subset of cases, no autoantibodies are detectable with the currently used routine assays. This study aimed to determine whether the levels of expression of aquaporin‐4 (AQP4), excitatory amino acid transporter 2 (EAAT2), or complement C3/C3d and C5b‐9 in human astrocytes following incubation with patient sera under inflammatory conditions differ between the various NMOSD subtypes and whether such differences can help to identify autoantibody‐mediated cases of NMOSD. Levels of AQP4, EAAT2, complement C3/C3d and C5b‐9 epitope expression on human astrocytes pretreated with various cytokines were quantitatively analyzed via indirect immunofluorescence after exposure to sera from patients with AQP4‐IgG seropositive, MOG‐IgG seropositive, and AQP4/MOG‐IgG double seronegative NMOSD. Significant differences in AQP4 and C3d epitope expression were observed, with IL‐17A, IL‐10, and IL‐6 pre‐treatment notably influencing astrocytic responses. Using uniform manifold approximation and projection (UMAP), patients were classified into clusters corresponding to AQP4‐IgG seropositive, MOG‐IgG seropositive, or double seronegative NMOSD. These results demonstrate distinct astrocytic staining patterns across NMOSD subtypes, providing a potential diagnostic tool for distinguishing between autoantibody‐mediated astrocytopathy and other cases. These findings suggest specific pathogenic mechanisms linked to each NMOSD subtype, which may have implications for tailoring therapeutic strategies based on cytokine involvement and astrocyte reactivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesAquaporin 4Neuromyelitis OpticaCytokinesEpitopesHumansFemaleAdultMaleAutoantibodiesMiddle AgedCells, Cultured

Stichwörter der Autor:innen

AQP4C3/C3dC5b‐9EAAT2IL‐6MOGADNMOSDastrocyte

Substanzen

Aquaporin 4AQP4 protein, humanCytokinesEpitopesAutoantibodies

Autor:innen und Institutionen

  • Experimental and Clinical Research Center, Max-Delbrück-Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Institute for Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
  • Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
  • Cluster of Excellence NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.

ORCID-Profile: Marlen Alisch, Volker Siffrin

Förderung

  • Roche
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Alisch, M., Foersterling, F., Zocholl, D., Muinjonov, B., Schindler, P., Duchnow, A., Otto, C., Ruprecht, K., Schmitz-Hübsch, T., Jarius, S., Paul, F., & Siffrin, V. (2025). Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine‐Primed Human Astrocytes. Glia. https://doi.org/10.1002/glia.24675

Vancouver

Alisch M, Foersterling F, Zocholl D, Muinjonov B, Schindler P, Duchnow A, et al. Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine‐Primed Human Astrocytes. Glia. 2025. doi:10.1002/glia.24675

BibTeX
@article{Alisch2025,
  author = {Alisch, Marlen and Foersterling, Franziska and Zocholl, Dario and Muinjonov, Bakhrom and Schindler, Patrick and Duchnow, Ankelien and Otto, Carolin and Ruprecht, Klemens and Schmitz-Hübsch, Tanja and Jarius, Sven and Paul, Friedemann and Siffrin, Volker},
  title = {Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine‐Primed Human Astrocytes},
  journal = {Glia},
  year = {2025},
  doi = {10.1002/glia.24675}
}
Kostenlos starten →